week. The "big boys" will continnue to buy this next week for themselves and their clients. The company should issue their "response to the F.D.A." press release this week which will spike the share price another 25-30%. The old share holder returning to buy and the funds buying with the upgrades should put this in the $9.00-$10.00 range by June 12. Good luck to all. Don't give away dollars for a few pennies.
Remember the following: 3 Drugs In Development - $85,000,000 in cash - No Debt - Potential $6 Billion market(s). Possible takeover candidate short term in the $15.00 range. This could realistically triple overnight at any time.